Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases

Clinical trial NCT07677293 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07677293
Sponsor: Peking University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma

Start date: 2026-06-26
Primary completion: 2028-12-31
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.